Core Laboratories Inc. (CLB) Profit Margins
Over the twelve months to 2026-06-30, Core Laboratories Inc. (CLB) had gross margin 19.5%, operating margin 9.2%, net margin 4.7%, free cash flow margin 2.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLBCore Laboratories Inc.Follow CLB — free
—
Price chart with a free account
- Market cap
- 454.7M
- P/E TTM
- 19.1
- Dividend yield
- 0.4%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Gross margin | 21.5% | 19.7% | 20.7% | 19.5% | |
| Operating margin | 10.7% | 11.2% | 10.7% | 9.2% | |
| Net margin | 7.2% | 6.0% | 5.6% | 4.7% | |
| FCF margin | 2.8% | 8.3% | 4.3% | 2.1% |
USD millions · SEC XBRL
Core Laboratories Inc. — questions
- What is Core Laboratories Inc.'s gross margin?
- 19.5% over the twelve months to 2026-06-30.
- What is Core Laboratories Inc.'s operating margin?
- 9.2% over the twelve months to 2026-06-30.
- What is Core Laboratories Inc.'s net profit margin?
- 4.7% over the twelve months to 2026-06-30.
Every figure on this page comes from Core Laboratories Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.